These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30568489)

  • 1. The association between metabolic syndrome and bladder cancer susceptibility and prognosis: an updated comprehensive evidence synthesis of 95 observational studies involving 97,795,299 subjects.
    Peng XF; Meng XY; Wei C; Xing ZH; Huang JB; Fang ZF; Hu XQ; Liu QM; Zhu ZW; Zhou SH
    Cancer Manag Res; 2018; 10():6263-6274. PubMed ID: 30568489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies.
    Ahmadinezhad M; Arshadi M; Hesari E; Sharafoddin M; Azizi H; Khodamoradi F
    Epidemiol Health; 2022; 44():e2022050. PubMed ID: 35638225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis.
    Feng D; Song P; Yang Y; Wei W; Li L
    Transl Cancer Res; 2021 May; 10(5):2188-2198. PubMed ID: 35116537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis.
    Zhao P; Xia N; Zhang H; Deng T
    Obes Facts; 2020; 13(4):384-396. PubMed ID: 32698183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
    Xie Y; Li P; Gao Y; Gu L; Chen L; Fan Y; Zhang F; Zhang X
    Oncotarget; 2017 Sep; 8(37):62489-62499. PubMed ID: 28977963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between pioglitazone use and the risk of bladder cancer among subjects with diabetes mellitus: a dose-response meta-analysis
.
    Li Z; Sun M; Wang F; Shi J; Wang K
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):210-219. PubMed ID: 28025963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of topical corticosteroids in pregnancy.
    Chi CC; Wang SH; Wojnarowska F; Kirtschig G; Davies E; Bennett C
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007346. PubMed ID: 26497573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studies.
    Schwingshackl L; Hoffmann G
    Cancer Med; 2015 Dec; 4(12):1933-47. PubMed ID: 26471010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.
    Tian Y; Ma Z; Chen Z; Li M; Wu Z; Hong M; Wang H; Svatek R; Rodriguez R; Wang Z
    PLoS One; 2016; 11(7):e0158891. PubMed ID: 27410033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis.
    Li J; Cheng Y; Liu G; Ji Z
    Onco Targets Ther; 2018; 11():3449-3459. PubMed ID: 29942137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.
    Fang H; Yao B; Yan Y; Xu H; Liu Y; Tang H; Zhou J; Cao L; Wang W; Zhang J; Zhao L; Chen X; Zhang F; Zhao Y
    Diabetes Technol Ther; 2013 Nov; 15(11):914-22. PubMed ID: 24180357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status.
    Zhang L; Wang Y; Qin Z; Li R; Cong R; Ji C; Meng X; Wang Y; Xia J; Song N
    J Cancer; 2018; 9(19):3522-3531. PubMed ID: 30310509
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects.
    Dai ZJ; Kang HF; Wang XJ; Shao YP; Lin S; Zhao Y; Ren HT; Min WL; Wang M; Liu XX
    Cancer Cell Int; 2014; 14(1):91. PubMed ID: 25253995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are mammographic density phenotypes associated with breast cancer treatment response and clinical outcomes? A systematic review and meta-analysis.
    Kanbayti IH; Rae WID; McEntee MF; Ekpo EU
    Breast; 2019 Oct; 47():62-76. PubMed ID: 31352313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
    Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
    Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Hormone Therapy on secondary diabetes mellitus in Breast Cancer: A Meta-analysis.
    Ye F; Wen J; Yang A; Wang Y; Li N; Yu P; Wei W; Tang J
    Clin Breast Cancer; 2022 Jan; 22(1):e48-e58. PubMed ID: 34429242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Night shift work and breast cancer risk: a meta-analysis of observational epidemiological studies.
    Van NTH; Hoang T; Myung SK
    Carcinogenesis; 2021 Oct; 42(10):1260-1269. PubMed ID: 34409980
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.